CD Bioparticles Announces Comprehensive Assay Portfolio for mRNA-LNP Vaccine
CD Bioparticles is pleased to announce a suite of mRNA-LNP Vaccine Laboratory Process Development Assays. CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is pleased to announce a suite of comprehensive mRNA-LNP Vaccine Laboratory Process Development Assays. This latest addition to CD Bioparticles’ extensive service portfolio...
0 Commenti 0 condivisioni 3K Views 0 Anteprima
Sponsorizzato
Sponsorizzato
Sponsorizzato
google-site-verification: google037b30823fc02426.html